Alira Health Contributes to 2022 Bioregion Report on the Future of Catalan Life Sciences

News
Category:
Published on:
February 13, 2023

We are pleased to announce that we are a key contributor to the just released 2022 Bioregion Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia, conducted by Biocat, BioRegion of Catalonia together with CataloniaBio & HealthTech and ACCIÓ. Our Market Access team aimed to analyze the main molecules that have entered the market based on innovation, and to identify those medical technology products that have accessed the market and how they have done so.

We were thrilled to contribute to the 2022 BioRegion Report, a one-of-a-kind in-depth analysis of the life sciences and biotechnology sector in Catalonia.
Chus Castillo Vice President Global Market Access Iberia, Alira Health

Some key findings from the report include –

  • Investment in startups and scaleups has exceeded all expectations in 2022, achieving 445 million euros in funding, boosted by the first mega round in the history of the BioRegion, captured by dental health medtech Impress, with 122 million euros.
  • Venture capital has once again been the primary source of financing, 95% of which involved international collaboration, followed by competitive grants (which have doubled compared to previous years), from the stock market, venture debt and crowdequity.
  • Financing from risk capital (venture capital) has once again been the main driver of this growth, accumulating 343 million euros, 77% of the total capital raised.
  • Foreign investment has also continued to hit record numbers. 95% of the total capital raised has included international investment companies. The number of international investment funds that have historically participated in operations has reached 117, a number that has doubled in the last three years.

This report was promoted at the presentation of the 2022 BioRegion Report on the 13th of February. The event was attended by institutional representatives of the Government of Catalonia and included a presentation of key indicators from the BioRegion Report and several expert round tables on innovation, investment and healthcare.

“We were thrilled to contribute to the 2022 BioRegion Report, a one-of-a-kind in-depth analysis of the life sciences and biotechnology sector in Catalonia. This report is a must-read for any stakeholder that is looking for a comprehensive overview of the activities of local companies, research facilities, and universities operating in the region. It provides a detailed view of the healthcare ecosystem in Catalonia as one of the leading regions in Europe in this sector,” said Chus Castillo, Vice President Global Market Access Iberia, Alira Health. “We hope that our contribution will enable healthcare companies to easily enter the Catalonian market and achieve maximum commercial success.”

Related news

Blog March 20, 2023
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
Drug Development Market Access Pharma
Events March 6, 2023
World EPA Congress 2023
We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)
Biotech Market Access Pharma Real-World Evidence
Blog March 6, 2023
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
Biotech Market Access MedTech
Events February 21, 2023
sTARTUp Day 2023
We are pleased to announce that we will be joining sTARTUp Day 2023 as speakers. This unique event will bring together startup-minded people to celebrate entrepreneurship in the city of Tartu.
Healthcare Technology Market Access Spain Startups
News February 21, 2023
Access and reimbursement pathways for digital health solutions and IVD devices
Digital therapeutics (DTx) are innovative solutions that use meaningful data to provide evidence-based decisions for the prevention, treatment, and management of diseases. Particular(...)
Diagnotics Digital Therapeutics Market Access Regulatory
News February 13, 2023
Alira Health Contributes to 2022 Bioregion Report on the Future of Catalan Life Sciences
We are pleased to announce that Alira Health is a key contributor to the just released 2022 Bioregion Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia.
Market Access
Events February 9, 2023
2022 BioRegion Report Presentation
We are excited to announce that we will be joining as speakers at the annual presentation of the 2022 BioRegion of Catalonia Report.
BioRegion Market Access
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.